| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.071 | 0.09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |